Skip to main content

FAST Graphs helps investors visualize a company’s earnings, valuation, dividends, and historical performance in one clear research platform. Compare price with fundamentals, identify potential overvaluation or undervaluation, and make decisions with greater confidence.

Research the business behind the stock.

Explore FAST Graphs Today

Disclosure: This advertisement may contain an affiliate link. I may earn a commission at no additional cost to you.

Nike’s 4.6% Dividend Yield: Turnaround Income Opportunity or Classic Yield Trap?

Nike has suddenly become something few investors ever expected it to be:

A high-yield dividend stock.

With NKE trading around $36, Nike's $0.41 quarterly dividend translates into an annualized payout of $1.64 and a yield of roughly 4.6%. Nike formally declared its latest $0.41 quarterly dividend on August 6.

That puts the yield in territory normally associated with utilities, banks and mature consumer staples—not one of the world's most recognizable athletic brands.

It is tempting to look at that 4.6% yield and see opportunity.

I see something more complicated.

Nike's dividend yield hasn't surged because management suddenly became extraordinarily generous.

The yield surged because the stock collapsed.

And when a dividend yield rises because the denominator is falling rather than because the numerator is rapidly growing, investors need to ask a much more important question:

Can the business comfortably afford the dividend?

For Nike, the latest numbers provide reasons for caution.

Nike's 4.6% Yield Comes With a Warning Label

Barron's reported on September 17 that Nike had fallen to approximately $36 per share, giving it the lowest share price among the Dow's 30 components and an approximately 4.6% dividend yield—the highest in the index. Nike is also scheduled to leave the S&P 100 on September 21 after its market capitalization fell to approximately $53 billion.

The index removal itself isn't particularly important to my investment thesis.

Nike doesn't sell fewer sneakers because it isn't in the S&P 100.

What matters is why its market capitalization has fallen far enough for this to happen.

That's where the story gets uncomfortable.

Nike generated $46.4 billion of revenue in fiscal 2026, essentially flat from $46.3 billion the previous year and down 2% on a currency-neutral basis. Nike Direct revenue fell to $17.7 billion from $18.8 billion.

Fiscal 2026 net income was $3.108 billion, down from $3.219 billion in 2025 and dramatically below the $5.7 billion generated in fiscal 2024. Diluted EPS was $2.10 compared with $3.73 only two years earlier.

That is the fundamental deterioration behind today's unusually attractive-looking yield.

The Dividend Coverage Test

This is the number I think income investors need to examine most closely.

During fiscal 2026, Nike generated:

Operating cash flow: $2.868 billion

Nike spent:

Capital expenditures: $684 million

That leaves approximately:

Free cash flow: $2.184 billion

Meanwhile, Nike paid:

Cash dividends: $2.407 billion.

In other words, using the straightforward operating-cash-flow-minus-capex definition, Nike's dividend consumed roughly:

110% of fiscal 2026 free cash flow.

That doesn't mean Nike is about to cut its dividend.

It does mean the dividend currently deserves much more scrutiny than its history alone might suggest.

The Dividend Is Still Being Paid

There is an important distinction between weak coverage and an imminent dividend cut.

Nike's board declared another $0.41 quarterly dividend in August, payable October 1, 2026.

The company also has significant financial resources.

At May 31, Nike held approximately $7.56 billion in cash and equivalents. Its debt structure included approximately $7.94 billion of total corporate term debt before separating the current portion, while no amounts were outstanding under its committed credit facilities.

So this isn't the balance sheet of a company obviously facing an immediate liquidity crisis.

The problem is different.

A dividend should ideally be supported by recurring business cash generation—not by the balance sheet indefinitely.

Nike therefore needs its turnaround to improve cash generation.

The Cash-Flow Deterioration Is Hard to Ignore

Fiscal 2026 operating cash flow fell to $2.868 billion from $3.698 billion in 2025.

Go back another year and the deterioration looks considerably larger: fiscal 2024 operating cash flow was approximately $7.429 billion.

That gives us:

FY2024 operating cash flow: $7.43B

FY2025: $3.70B

FY2026: $2.87B

That's the trend income investors should be studying.

The dividend itself isn't necessarily the problem.

The shrinking cash-flow cushion underneath it is.

Nike Already Made the Right Decision on Buybacks

One encouraging development is that Nike has dramatically reduced share repurchases.

The company spent nearly $3 billion buying back stock in fiscal 2025.

Fiscal 2026 repurchases fell to approximately $146 million of cash-flow expenditure, while Nike said it had paused repurchases during the year.

That is exactly where I believe capital allocation should be heading.

Nike still had approximately $5.9 billion remaining under its authorized repurchase program at fiscal year-end, but management has made clear that future purchases depend on operating cash flow, liquidity needs and market conditions.

At this stage of the turnaround, I would much rather see Nike protect:

the balance sheet,

the dividend,

and investment in the brand

before aggressively repurchasing shares.

A $36 stock might eventually prove to be an extraordinary buyback opportunity.

But only if the underlying business recovers.

The Dividend Doesn't Need Explosive Growth—Nike Does

This is where the turnaround mathematics become interesting.

At the current annualized dividend of $1.64, Nike needs roughly $2.4 billion annually to fund its dividend at today's approximate share count.

If free cash flow returned to $3 billion, dividend coverage would become much more comfortable.

At $4 billion, the dividend would consume approximately 60% of free cash flow.

At $5 billion, it would consume less than half.

That means Nike doesn't need to return immediately to its former peak cash-generation levels to make today's dividend look much safer.

It simply needs meaningful operating recovery.

And that is why the stock has become fascinating.

The Bull Case

Nike remains one of the most powerful athletic brands in the world.

The company generated $46.4 billion in FY2026 revenue despite its problems.

This isn't a tiny company desperately trying to establish a consumer franchise.

The franchise already exists.

The challenge is restoring growth, product excitement and profitability.

If Nike succeeds, today's dividend yield could look extraordinary in hindsight.

Imagine buying Nike around a 4.6% yield and then watching earnings and free cash flow recover while the company continues increasing its dividend.

Investors could potentially receive both income and substantial capital appreciation.

That is the turnaround-income thesis.

The Bear Case

The alternative is much less attractive.

Nike's revenue stagnates.

Margins remain pressured.

Consumer enthusiasm shifts toward competitors.

Direct sales continue struggling.

Cash flow fails to recover.

The stock remains depressed.

And eventually the dividend begins competing with reinvestment needs for increasingly scarce cash.

That's how a 4.6% yield becomes a yield trap.

The danger isn't that 4.6% is unusually high.

The danger is why it became 4.6%.

Barron's noted that most analysts covering Nike were characterized as having Hold or Sell ratings, with continued concerns about sales weakness and additional reductions to earnings estimates.

The market is clearly demanding proof of recovery.

The Index Drama Doesn't Matter Much

Nike's removal from the S&P 100 will generate headlines.

Potential removal from the Dow will generate even more.

But I wouldn't build an investment thesis around either.

Nike's approximately 0.4% weighting in the price-weighted Dow already makes its influence on the index relatively small. Any discussion about future Dow removal remains speculation rather than an established event.

The more important questions are much simpler:

Are consumers buying Nike products?

Is product innovation improving?

Are margins recovering?

Is free cash flow growing?

Can cash flow comfortably cover the dividend?

Those factors will determine shareholder returns—not an index committee.

How Much Recovery Does Nike Need?

This is the question that makes today's valuation intriguing.

Fiscal 2026 net income was approximately $3.1 billion, compared with $5.7 billion in fiscal 2024.

Nike doesn't necessarily need to return immediately to $5.7 billion.

Even a recovery toward $4 billion–$4.5 billion of annual earnings accompanied by stronger cash conversion could dramatically change investor perception.

At the same time, restoring free cash flow comfortably above $3 billion would substantially improve dividend coverage.

That's the threshold I would watch.

I don't need Nike to become the old Nike overnight.

I need evidence that the financial trajectory has stopped deteriorating.

My Nike Price Forecast

At approximately $36, I believe the market has already priced substantial pessimism into Nike.

But a low stock price isn't automatically a cheap stock when earnings are falling.

That makes my forecast unusually dependent on turnaround execution.

Bear Case: $25–$30

Nike's turnaround fails to gain traction, earnings estimates continue falling, free cash flow remains insufficient to comfortably cover dividends and investors begin questioning the payout itself.

At that point, the apparently attractive yield could become an even higher yield for all the wrong reasons.

Base Case: $45–$52 by September 2027

My central estimate is approximately:

$48 per share by September 2027.

This assumes Nike stabilizes revenue, begins rebuilding margins, restores healthier cash generation and demonstrates that the dividend can be supported through operating performance rather than balance-sheet flexibility.

From approximately $36, $48 would represent about 33% potential price appreciation, before dividends.

Bull Case: $60–$70

This requires a genuine brand and product turnaround.

New products gain traction.

Revenue returns to sustainable growth.

Margins expand.

Free cash flow recovers toward $4 billion or better.

And investors begin valuing Nike as a global growth brand again rather than a mature company in structural decline.

Under that scenario, today's 4.6% dividend yield could prove to have been one of the more unusual income opportunities in Nike's history.

My Rating: HOLD — High-Risk Turnaround Income

For now, I'm rating Nike:

HOLD

The yield is attractive.

The brand is exceptional.

The valuation has fallen dramatically.

But I don't believe dividend investors should confuse a high yield with a strong dividend.

Those are different things.

Nike paid approximately $2.407 billion in dividends during fiscal 2026 while generating roughly $2.184 billion of conventional free cash flow.

Until that relationship improves, I want more evidence before treating NKE as a traditional dividend opportunity.

What Would Make Me Upgrade Nike to Buy?

The first thing I want to see is free cash flow comfortably exceeding the dividend again.

Not barely.

Comfortably.

A sustained move above roughly $3 billion in annual free cash flow would substantially improve the picture.

Second, I want evidence that Nike's revenue problems are stabilizing and its product strategy is translating into improved consumer demand.

Third, margins need to recover.

Finally, I want buybacks to remain secondary until cash generation strengthens.

If those pieces fall into place, the investment thesis changes considerably.

Bottom Line

Nike's 4.6% dividend yield looks extraordinary because it is extraordinary.

But investors need to understand how it got there.

Nike didn't suddenly transform itself into an income machine.

Its stock price collapsed while its business weakened.

Fiscal 2026 revenue was essentially flat. Net income remained far below fiscal 2024 levels. Operating cash flow fell to $2.868 billion, and conventional free cash flow of roughly $2.184 billion was below the approximately $2.407 billion paid in dividends.

That's not the financial profile I normally associate with a safe high-yield dividend stock.

But Nike isn't a normal distressed company either.

It still possesses an extraordinary global brand, billions of dollars in liquidity and a business capable of generating tremendous cash flow if management can restore its competitive momentum.

That leaves investors with one of the more interesting turnaround questions in the Dow:

Is Nike's 4.6% yield compensation for temporary pain—or a warning that the market sees deeper problems ahead?

For now, I'm collecting the dividend rather than chasing the turnaround.

If cash flow begins recovering, that could change quickly.

Investment rating: HOLD. Base-case 12-month target: approximately $48. Price targets are scenario estimates, not guarantees or individualized investment advice.

Comments

Popular posts from this blog

Lennar Cut Construction Costs 6%—So Why Did Earnings Collapse 52%?

Lennar just demonstrated one of the strangest contradictions in the American housing market. The company is building homes faster. Construction costs are falling. Its land-light strategy is reducing the amount of capital trapped in land. Inventory management is improving. And yet earnings per share fell almost 48% , from $2.29 to $1.19. That isn't what operational improvement is supposed to look like. But Lennar's third-quarter 2026 results reveal something increasingly important about the housing market: America can simultaneously have a structural housing shortage and an affordability crisis severe enough to crush homebuilder profitability. That's exactly what appears to be happening. Lennar's Quarter in One Sentence Lennar produced approximately $8.0 billion in revenue , delivered 20,840 homes and generated 20,879 new orders during the quarter. But orders declined 9% year over year, deliveries declined 3%, and earnings deteriorated sharply. The comparison with last y...

Agilent Technologies: A “Long Runway” Bet on the Future of Therapeutics

Agilent Technologies: A “Long Runway” Bet on the Future of Therapeutics Byline: Market Analysis & Forecast When Agilent Technologies CEO Padraig McDonnell talks about a “long runway” in advancing therapeutics, he isn’t making a vague optimism play—he’s pointing directly at one of the most structurally durable growth trends in healthcare. And increasingly, the company is positioning itself to monetize that runway. The News Behind the Narrative McDonnell’s bullish tone comes as Agilent doubles down on its role in drug development infrastructure—particularly in diagnostics, pathology, and therapeutic manufacturing. Recent moves reinforce that thesis: Agilent launched Advanced Therapeutics , consolidating CDMO (contract development & manufacturing) capabilities across North America ( Yahoo Finance ) It is acquiring Biocare Medical for $950M , expanding its footprint in cancer diagnostics and pathology workflows ( Reuters ) The company continues to push into precision oncology and b...

Alico (ALCO): Hidden Land Value Play or Value Trap in Transition?

Byline: Market Analysis & Forecast Alico isn’t your typical stock—it’s not really an agriculture company anymore. Based on recent CEO commentary, it’s becoming something else entirely: 👉 a land monetization and real estate development story hiding inside an old citrus business And management is making that shift very clear. “We’ve built a balanced platform… to unlock substantial value from our ~46,000-acre portfolio.” Activate Up to $100 Cash Back That’s not subtle. The News: A Full-Blown Transformation Alico is exiting citrus operations and pivoting toward: Land sales Land leasing Real estate development This is a massive strategic shift. Key Highlights: Adjusted EBITDA: +$2.7M (vs -$6.7M last year) Land sales: $34.5M+ recent activity 97% of farmable land now leased Portfolio value: $650M–$750M (management estimate) Meanwhile: 👉 Market cap is roughly ~$300M range That gap is the entire thesis. The Investment Thesis: This Is a Land Arbi...